Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

BHARAT PARENTERALS LTD.

NSE : NABSE : 541096ISIN CODE : INE365Y01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE1128.8067.8 (+6.39 %)

PREV CLOSE ( ) 1061.00

OPEN PRICE ( ) 1098.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 630

TODAY'S LOW / HIGH ( )1097.95 1129.95

52 WK LOW / HIGH ( ) 8021771.95

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992

Management Info

Bharat Desai - Chairman Bharat Desai - Managing Director

Registered Office

Address Survey No. 144 A,Jarod - Samlaya Road,Haripura, Savli,
Vadodara,
Gujarat-391520

Phone 02667 - 251670, 251680, 9909928332

Email info@bplindia.in / cs@bplindia.in

Website www.bplindia.in

Registrars Details

Adroit Corporate Services Pvt Ltd

18-20, 1st floor, Plot No 639,Makwana Road,,Marol, Andheri (East),Mumbai

Listing : BSE

NEWS

09Dec Bharat Parenterals informs about repo
In accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/..

04Dec Bharat Parenterals informs about newsp
Pursuant to Regulation 30 of SEBI Listing Regulation, Bharat Parenterals..

28Nov FAMHP concludes EU GMP inspection at f
Federal Agency for Medicines and Health Products, Belgium (FAMHP) has co..

27Nov Bharat Parenterals informs about analy
Bharat Parenterals has informed that representatives of the Company will..

04Sep Bharat Parenterals informs about AGM
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	27.3	264.5
Gross Profit	34.2	363.1
Operating Profit	65.5	481.5
Net Sales	417	3041.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Amrutanjan Healthcar (BSE) 689.65 (6.38%)	M.Cap ( in Cr)1993.82
Lupin (BSE) 2114.10 (1.62%)	M.Cap ( in Cr)96571.84
Panacea Biotec (BSE) 362.70 (9.53%)	M.Cap ( in Cr)2221.56
Emcure Pharma (BSE) 1439.60 (2.18%)	M.Cap ( in Cr)27289.76
Aurobindo Pharma (BSE) 1193.70 (1.81%)	M.Cap ( in Cr)69330.29

Shareholding Pattern

	PROMOTERS	67.19%
	NON-INSTITUTION	32.15%
	FI/BANKS/INSURANCE	0.01%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

BHARAT PARENTERALS LTD.